16 results
10-K/A
2022 FY
CADL
Candel Therapeutics Inc
1 May 23
Annual report (amended)
8:01am
and right of first refusal and
co-sale
agreements containing registration rights, information rights, voting rights and rights of first refusal, among
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
agreements containing registration rights, information rights, voting rights and rights of first refusal, among other things, with certain holders of our
S-3
CADL
Candel Therapeutics Inc
5 Aug 22
Shelf registration
5:08pm
stock do not have any cumulative voting rights. Upon our dissolution, liquidation or winding up, holders of our common stock are entitled to share … adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change
10-K
EX-4.2
sn55t1
29 Mar 22
Annual report
8:46am
8-K
EX-3.2
zd5ursdmxilpg5
30 Jul 21
Departure of Directors or Certain Officers
12:00am
424B4
40a41aeu
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-4.4
5ywzhf1t4a1a 1mnism
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-3.1
gt2uujpc
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-4.3
uhlv6zmp7mj
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.6
7jaw2k6q49i0c9h
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
p8ace15c15 qppm36
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-4.5
ihmtggxauppq995 9t
25 Jun 21
IPO registration
5:28pm
S-1
le436e
25 Jun 21
IPO registration
5:28pm
DRS/A
v84z yhwf1tcf4tj5
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next